Jefferies Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-34,179
Closed -$1.02M 2793
2019
Q1
$1.02M Buy
+34,179
New +$980K 0.01% 1266
2018
Q4
Sell
-10,142
Closed -$384K 2452
2018
Q3
$384K Sell
10,142
-1,666
-14% -$63K ﹤0.01% 1747
2018
Q2
$453K Buy
11,808
+2,998
+34% +$101K ﹤0.01% 1645
2018
Q1
$297K Buy
+8,810
New +$338K ﹤0.01% 1805
2017
Q4
Sell
-18,105
Closed -$907K 2728
2017
Q3
$907K Buy
18,105
+3,300
+22% +$169K 0.01% 1330
2017
Q2
$782K Buy
14,805
+7,158
+94% +$384K 0.01% 1404
2017
Q1
$425K Buy
+7,647
New +$422K ﹤0.01% 1682

Other funds holding PBH

Jefferies Group's PBH Position: Q2 2019 in Review

Jefferies Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2019, closing a stake of 34,179 shares — an estimated $1.02M sold.

Jefferies Group first reported a position in PBH in Q1 2017 and held it in 7 quarters. The position peaked at $1.02M in Q1 2019. 212 funds tracked by Wall St. Rank hold PBH as of Q2 2019.

  • Jefferies Group reported no remaining Prestige Consumer Healthcare position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 34,179 Prestige Consumer Healthcare shares in Q2 2019, an estimated $1.02M.
  • Jefferies Group first reported a position in Prestige Consumer Healthcare in Q1 2017 and held it in 7 quarters.
  • Jefferies Group's Prestige Consumer Healthcare position peaked at $1.02M in Q1 2019.
  • 212 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.